ArticleCureus2024
Improving Adherence to National Institute for Health and Care Excellence (NICE) Guidelines for the Use of Tranexamic Acid in Primary Total Knee Arthroplasty: A Quality Improvement Initiative.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranexamic acid (TXA) is a pharmacological agent used in reducing blood loss during orthopaedic surgeries, including total knee arthroplasty (TKA). Despite its proven efficacy and National Institute for Health and Care Excellence (NICE) guidelines recommending combined topical and intravenous administration, compliance in clinical practice often lags.
objectiveThis study aimed to evaluate and improve adherence to NICE guidelines for TXA use during TKA through a quality improvement initiative.
methodsA two-cycle audit was conducted at Good Hope Hospital, Birmingham, United Kingdom, assessing compliance with TXA guidelines in 93 TKA cases reviewed retrospectively. Educational interventions including presentations, emails, and instructional posters, were implemented between cycles to address non-compliance barriers. Data from operation notes were analyzed, and adherence improvements were evaluated using statistical tests.
resultsThe first cycle revealed a 51.2% non-compliance rate. Following interventions, compliance improved significantly, with TXA usage rising from 48.8% to 73.1% (p = 0.016). Combined topical and intravenous administration increased from 7.3% to 30.8% (p= 0.005). Subgroup analyses of the second cycle indicated better compliance in non-tourniquet cases and improved adherence among patients with renal impairment.
conclusionTargeted educational interventions significantly improved adherence to TXA guidelines in TKA. Incorporating TXA administration into surgical checklists and further education on its safety, especially in patients with renal impairment, may be helpful in improving compliance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.